Ready-made ETF portfolios built for real investor needs. Explore now →

Advertisement
Segment| Data as of 09/08/2026
trending up

Cannabis & Psychedelics ETFs

1D perf
0.3%
1D flows
-$4M
Total AuM
$1.30B
Total ETFs
6

Aggregate data of 6 funds

Performance

051015%Aug 10Aug 17Aug 24Aug 31Sep 7

Flows

-30 M-20 M-10 M0 M10 M
1M3MYTD1Y3Y5Y
Perf.+15.70%-5.08%+8.38%+7.90%-26.59%
Flows-$25M-$52M-$46M+$71M+$758M-

Top ETFs in this segment

1D+0.31%1W flows-View
1D+0.61%1W flows-View
1D+0.19%1W flows-View

Just published in Cannabis & Psychedelics

View all articles

Rescheduling Is Real: What the DOJ’s Cannabis Order Means for MSOS Investors and the Broader Sector

Federal cannabis rescheduling may mark the biggest structural shift for cannabis ETFs in years, improving taxes, banking access, and investment potential.

Cannabis Rescheduling
AdvisorShares
By AdvisorShares · April 29, 2026

Movers in Cannabis & Psychedelics

Top
Bottom
Top performers, 1 week1W perf.YTD perf.
MSOS
AdvisorShares Pure US Cannabis ETF+3.78%+8.81%
CNBS
Amplify ETF TR Seymour Cannabis - USD+3.58%+4.19%
WEED
Roundhill Cannabis ETF - USD+3.52%+15.39%
YOLO
AdvisorShares Pure Cannabis ETF+3.18%-3.20%
MJ
Amplify Alternative Harvest ETF - USD+1.55%-9.43%
Top inflows, 1 week1W flowYTD flows
MSOS
AdvisorShares Pure US Cannabis ETF--$2M
YOLO
AdvisorShares Pure Cannabis ETF--$4M
PSIL
AdvisorShares Psychedelics ETF-+$26M
WEED
Roundhill Cannabis ETF - USD-$1M-$2M
CNBS
Amplify ETF TR Seymour Cannabis - USD-$3M-$24M

Data period: September 1 - 8, 2026

Performance lists exclude leveraged and inverse ETFs

Latest news about Thematic Investing: Cannabis & Psychedelics

Rescheduling Is Real: What the DOJ’s Cannabis Order Means for MSOS Investors and the Broader Sector

Federal cannabis rescheduling may mark the biggest structural shift for cannabis ETFs in years, improving taxes, banking access, and investment potential.

Cannabis Rescheduling
AdvisorShares
By AdvisorShares · April 29, 2026

A Historic Executive Order: What Federal Action on Psychedelics Means for the Mental Health Landscape

Federal policy has officially caught up with the science and the implications for the psychedelic healthcare sector are significant.

A Historic Executive Order: What Federal Action on Psychedelics Means for the Mental Health Landscape
AdvisorShares
By AdvisorShares · April 22, 2026

Is U.S. Cannabis Finally Becoming Investable?

Rescheduling alters operating economics in a historically constrained sector.

Cannabis Schedule III
AdvisorShares
By AdvisorShares · December 19, 2025

How Could the Federal Limitations on Intoxicating Hemp Reshape Cannabis Investments?

New federal hemp restrictions and rising rescheduling momentum are reshaping the outlook for cannabis ETFs and U.S. operators.

Cannabis
AdvisorShares
By AdvisorShares · November 21, 2025

Is Cannabis Policy Shifting From Politics to Profits?

Federal cannabis rescheduling could reshape U.S. markets. Here’s what it means for businesses, policy, and cannabis ETFs eyeing new growth opportunities.

Cannabis legislation ETF
AdvisorShares
By AdvisorShares · August 22, 2025

Can Psychedelics Heal Minds and Grow Portfolios?

Psychedelics offer hope for mental health treatment and attract investors despite biotech-like volatility and market shifts.

Psychedelic Portfolios ETFs
AdvisorShares
By AdvisorShares · April 17, 2025

Why 2025 Could Be the Biggest Year Yet for Psychedelics and Investors

2025 sees a surge in psychedelic policy reforms, RFK Jr.’s nomination, and growing investor confidence in mental health treatment breakthroughs.

Psychedelics ETFs
AdvisorShares
By AdvisorShares · February 13, 2025

Why the DEA’s Cannabis Rescheduling Delays Matter—and How Advocates Are Fighting Back

Cannabis rescheduling hearings face delays and controversies, reflecting reform complexities and challenges for U.S. advocates.

DEA Cannabis
AdvisorShares
By AdvisorShares · January 27, 2025

The Worst Performing ETFs of 2024

Looking at which ETFs had the poorest returns last year.

Worst Performing ETFs of 2024

From Potential to Policy: Cannabis in a New Political Climate

Shifting political tides and GOP support could drive cannabis growth, offering investment opportunities amid evolving U.S. policies.

Cannabis
AdvisorShares
By AdvisorShares · November 28, 2024
Advertisement
Advertisement
Advertisement
ETF U
Become a better investor with NYSE: The Home of ETFs
Visit the ETF U homepage
ETF Guides

Recent educational content

Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs September 8, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 9, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 31, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · September 1, 2026
Tidal ETF Industry KPIs

ETF Trends

ETF Industry KPIs August 24, 2026

This week’s KPI data overview highlights key metrics and trends shaping the ETF landscape.

Tidal
By Tidal · August 24, 2026
What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

What’sTheFund

What's the Fund | Ocean Park Diversified Income ETF (DUKZ)

James St Aubin, Chief Investment Officer at Ocean Park Asset Management, discuss the DUKZ ETF, exposing investors to the whole spectrum of asset classes in the fixed income markets, through their rules-based process.

NYSE logo
By NYSE · August 18, 2026

Browse all educational columns

The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up